A thread based on slides I am presenting at @theNASEM on Oct 10. This is part of advising for the National Institute of Aging as it plans funding programs for the primary prevention of #dementia and #Alzheimer's Disease. Here we go...
@theNASEM Exercise has been shown to be perhaps the most effective neuroprotective intervention. This evidence is mainly based on animal research but some has been corroborated by human studies. At this point, no other intervention can claim the same conglomeration of benefits on the brain
According to a meta-analysis in 2018 exercise has a medium positive effect on cognition in individuals with mild cognitive impairment and Alzheimer's. However, most studies are small and some effects seem implausibly large.
These results follow the unforgettable conclusion of the 2010 @NIH consensus meeting, in which exercise was grouped alongside "other leisure activities" such as painting and religious services, intentionally or unintentionally giving the impression that the evidence is similar.
Likewise, who can forget the 2011 review commissioned by the @CDCgov, which could not find evidence that exercise can improve cognition in older adults. The "multidisciplinary panel" did not include researchers from exercise science.
At this point, we're facing a new reality because most major pharmaceutical companies have pulled out of the race to find a drug for Alzheimer's Disease, after having an astounding 99.6% failure rate. Perhaps the problem is the long fixation on the "amyloid cascade hypothesis."
Which brings us to the amazing study by Choi et al. (2018) in @ScienceMagazine, which basically said that a good way to move forward in new drug development would be to try to ...mimic the effects of exercise. Or, you know, getting people to exercise might be a good option too...
In my mind, it is crucial to take advantage of biomarkers, such as PiB PET. Once amyloid buildup has taken place, this should be considered the treatment phase. Once cognitive symptoms have appeared, it's probably already too late to intervene.
According to estimates, by the time symptoms such as memory loss appear, amyloidosis has "maxed out" and there is atrophy, measurable by volumetric MRI and FDG-PET. This is why I think recruiting patients with Alzheimer's diagnosis or even Mild Cognitive Impairment is too late.
So, let's look at the current approach to encourage physical activity among older adults. The 2018 Physical Activity Guidelines follow the same approach as always: (1) try to convince old folks it's good for them, (2) give them specific numerical targets they need to achieve.
Let's look at each part separately. "Do it, it's good for you" reflects reliance on the fundamental assumption of rationality. If you give people the "right" information (enough, correct, compelling), they must act since they are rational creatures interested in their health, no?
So, at this point, all our exercise-promotion interventions are based on the use of information designed to appeal to people's rationality in one way or another (e.g., cultivate risk appraisals, convince that benefits outnumber barriers, boost self-efficacy).
By doing so, the promotion of exercise and physical activity has fallen behind the times by a couple of decades. We have yet to discuss the issue of "bounded rationality" that has been recognized in other disciplines. And we have yet to discuss "heuristics and biases." Why?
Meanwhile, there are intriguing indications that exercise may be unique among health behaviors in that knowledge of its benefits is almost entirely disconnected from the propensity to engage in the behavior: 97% of Americans know it's good for them, yet 97% don't do enough of it.
And our interventions seem to be only borderline effective. But the effectiveness drops with larger samples, longer follow-ups, and trials of higher methodological quality. At this point, the average effect seems to be around 0.20 of a standard deviation, a "small" effect.
To put this number into perspective, that's also the effect of the so-called "question-behavior effect" or "mere measurement effect," namely the apparent change in (mostly self-reported) behavior as a result of just inquiring about the behavior by administering a questionnaire.
And, a dirty little secret is that which of our time-honored theories one uses as the basis of the exercise- or activity-promotion intervention makes little to no difference.
And, in fact, using a psychological theory or not using a psychological theory also does not seem to make a difference. Oh my!
Let's also talk about the 2nd part of physical activity guidelines: "this is how much you should be doing." This is based mainly on information from epidemiologic (i.e., correlational) studies. A recommendation is given that balances benefit (risk approaches a plateau) and risk.
Using the balance of "benefit" and "risk" to decide dosage follows the reasoning used in developing pharmaceutical prescriptions. But exercise is a behavior people must perform willingly. So, what's missing? Perhaps the "affect heuristic"?
Perhaps, in addition to our cognitive appraisals, we also need to consider the role of affective constructs such as pleasure and enjoyment. In the last several years, researchers have been trying to find ways to make exercise more pleasant. It's not easy but it may be possible.
Can "affect" be measured? Yes, although this may be one of the most convoluted and confusing domains of psychological theory and assessment. I have tried to do my part by putting together a century's worth of literature into a short and readable guidebook. I hope it can help.
Moreover, with researchers from around the world, we have been able to decipher the dose-response relation between exercise intensity & affective responses. This discovery now allows us to build a three-legged stool, if we wish: (1) benefit, (2) risk, AND (3) pleasant experiences
And, we would be remiss if we din't mention that the activation of the endocannabinoid system (which may, to some extent anyway, underlie positive affective responses to exercise) may be required or at least may be involved in the upregulation of neurotrophins such as BDNF.
The first interventions designed to manipulate affective responses to examine the effects on long-term exercise or physical activity behavior have started to appear, with promising results. The studies are still small because funding is still in short supply. Change takes time...
So, with @RalfBrandGER, we have proposed the Affective-Reflective Theory (ART), according to which it is not sufficient to change the cognitive appraisals postulated by our current theories. It is also necessary to cultivate positive affective associations of "exercise."
Kahneman and exercise science? What is the relevance of the scientific legacy of the great Israeli psychologist and Nobel laureate to the science of physical activity? It's much more than you think. A thread -- and a tribute...
Let's start from this. Imagine that you bring together the world's best physical activity epidemiologists, experts in physical activity assessment, exercise physiologists, and sports medicine physicians. You put them in a room at the @WHO headquarters and ask them to develop the next physical activity guidelines. What are they going to come up with?
In the absence of input from the behavioral sciences, the team will likely follow what I call the "common sense approach" to developing physical activity guidelines. For example, analyze the @WHO guidelines. The part at the top gives the rationale for physical activity.
In November 2020, my students and I discovered a completely fake meta-analysis, now cited more than 100 times. I notified @Hindawi but, as shown below, they have no intention to act. Each year, on the anniversary of the discovery, I re-post this thread...
This is the meta-analysis in question, supposedly summarizing RCTs examining the effects of exercise in patients with chronic renal failure. Note that the APC for "BioMed Research International" is $2,550.
Also note that @WileyGlobal bought @Hindawi in 2021 for $298 million, evidently unbothered by the fact that @Hindawi is generally not considered a reputable scientific publisher.
Steve Blair, an iconic figure in the field of exercise science over the past four decades, has passed away at the age of 84. He is leaving behind an enormous legacy. I would like to share a few thoughts...
In my mind, Blair was the last of the trio of physical activity epidemiologists that gave our field a prominent place in contemporary medicine and public health. We lost Jerry Morris on Oct 28, 2009. We lost Ralph Paffenbarger on Jul 9, 2007. We lost Steve Blair on Oct 6, 2023.
Parenthetically, if you are interested, the @ACSMNews has a wonderful 22-minute video at the YouTube link below, featuring a conversation with Blair and Paffenbarger. Highly recommended.
This sort of headlines (what you thought you knew is actually false) are becoming increasingly common. While we can debate their scientific value, one thing is for sure: they are *wonderful* training opportunities for Kinesiology / Exercise Science students. Let's take a look...
The first thing to note is that these headlines are happening against the backdrop of tremendous activity in the dementia field following the flop of Aducanumab (Aduhelm). Now, there is lecanemab, also a monoclonal antibody, with similar side-effects (brain swelling, bleeding).
So, let's look at the study in question. The MEDEX (Mindfulness, Education, and Exercise) randomized controlled trial ($3M) aimed to compare mindfulness-based stress reduction and exercise, alone or in combination, with a control intervention (health ed).
Today is the first formal step toward the culmination of a 10-year process of trying to analyze and comprehend the phenomenon of HIIT within exercise science. Paper II (from a set of 6) with @NBTiller is the first to become available online (DM for PDF).
In this paper, @NBTiller and I address the increasing prevalence of "spin" by examining 4 extraordinary claims that appeared in the HIIT research literature and subsequently made a splash as media headlines. We dissect the underlying research used as the basis for these claims.
What we find is a narrative that has run amok, becoming disconnected from the data; blatant neglect of basic methodological and statistical principles; serious errors of reporting; a striking absence of critical appraisal by journals, university press offices, and the mass media.
When you read that power calculations determined that a sample size of "8 per group" sufficed to provide 80% power, do you get a queasy feeling in your stomach? Like something ain't right? And does the paper start to smell fishy all of a sudden? Don't you get the urge to verify?
So, your stomach would be correct. Let's set aside for a moment that expecting 50% superiority from an 8-week intervention is kind-of ludicrous. Since 50% of 15 is 7.5, comparing 15±5 to 22.5±5 gives d=0.61, which requires 43 per group (not 8) to reach 80% power.
Then, you read that VO2peak changed from 22.6±8.2 to 24.7±7.9 (+2.1 ml) in one group and from 23.2±5.4 to 26.7±5.8 (+3.5 ml) in the other but "improvements in CRF" were "larger" in the latter group (with N=10 per group). Don't you get a strange feeling that those means are close?